Progress on pharmacological activities and mechanism of Anemarrhena saponin

LIU Yanping

doi:10.3969/j.issn.1006-0111.2018.01.005

Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review, editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name

E-mail

Phone

Title

Content

Verification Code

Volume 36 Issue 1

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Practice and Service > 2018 > 36(1): 24-29

LIU Yanping. Progress on pharmacological activities and mechanism of Anemarrhena saponin[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(1): 24-29. doi: 10.3969/j.issn.1006-0111.2018.01.005

Citation:

LIU Yanping. Progress on pharmacological activities and mechanism of Anemarrhena saponin[J]. Journal of Pharmaceutical Practice and Service, 2018, 36(1): 24-29. doi: 10.3969/j.issn.1006-0111.2018.01.005

Progress on pharmacological activities and mechanism of Anemarrhena saponin

doi: 10.3969/j.issn.1006-0111.2018.01.005

LIU Yanping

Pudong New Area People's Hospital, Shanghai 201200, China;Shanghai Yangpu Hospital Affiliated to Tongji University, Shanghai 200090, China

Received Date: 2017-06-15
Rev Recd Date: 2017-09-20

Abstract

As a traditional Chinese medicine, Anemarrhena saponin is one of the main components in Anemarrhena. Many pharmacological activities were reported in recent literatures, such as anti-tumor, anti-senile dementia, improving learning and memory, anti-clotting, anti-thrombus, reducing blood glucose and lipid, anti-depression, lowering blood pressure, and so on. In this paper, the pharmacological effects of the Anemarrhena saponin were summarized in four aspects which are anti-tumor, central nervous system, cardiovascular system and endocrine system to provide an important basis for further development of Anemarrhena.
- Anemarrhena saponin,
- pharmacological activity,
- research progress

References

[1]	国家药典委员会. 中华人民共和国药典2015年版(一部)[S]. 北京:中国医药科技出版社,2015.
[2]	王迪,姜艳艳,石任兵. 中药知母质量控制方法研究[J]. 北京中医药大学学报,2011,34(4):263-265.
[3]	孙小明. 知母化学组分特征及其影响因素研究[D]. 北京:北京中医药大学,2008.
[4]	戴骏宇,喻凯,王明奎. 知母皂苷OfficinalisininⅠ对心肌缺血的保护作用及其机制研究[J]. 中药药理与临床,2017,3(3):27-30.
[5]	廖子君,张晓明,郭亚焕,等. 菝葜皂苷元对胃癌BGC-823细胞增殖、凋亡影响的实验研究[J]. 现代肿瘤医学,2010,18(6):1085-1087.
[6]	Ni Y,Gong XG,Lu M.,et al. Mitochondrial ROS burst as an early sign in sarsasapogenin-induced apoptosis in HepG2 cells[J]. Cell Biol Int,2008,32(3):337-343.
[7]	Bao WN,Pan HF,Lu M, et al. The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells[J]. Cell Biol Int,2007,31(9):887-892.
[8]	King FW,Fong S,Griffin C,et al. Timosaponin AⅢ is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress[J]. PLoS ONE,2009,4(9):e72-83.
[9]	Sy LK,Yan SC,Lok CN,et al. Timosaponin A-Ⅲ induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells[J]. Cancer Res,2008,68(24):10229-10237.
[10]	Kang YJ,Chung HJ,Nam JW,et al. Cytotoxic and antineoplastic activity of timosaponin A-Ⅲ for human colon cancer cells[J]. J Nat Prod,2011,74(4):701-706.
[11]	潘会君,莫小辉,冯彦军,等. 知母皂苷AⅢ对人脐静脉内皮细胞增殖和凋亡的影响[J].中国药房,2014,25(43):4049-4051.
[12]	潘会君,陈中建,章丹丹. 知母皂苷AⅢ对2种黑色素瘤细胞生长及巨噬细胞活化的影响[J]. 中国药师,2015,18(2):181-185.
[13]	潘会君,史海霞,陈中建,等. 知母皂苷AⅢ对黑色素瘤B16细胞生长和Bax,Bcl-2 mRNA的影响[J]. 中药新药与临床药理,2015,26(1):48-52.
[14]	Kim KM,Im A,Kim SH,et al. Timosaponin AⅢ inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis[J].Cancer Science,2016,107(2):181-188.
[15]	谭希,潘会君,吴伟达,等. 知母皂苷AⅢ抑制人脑胶质瘤增殖生长的机制研究[J]. 中国中药杂志,2017,42(6):1160-1166.
[16]	潘会君,聂绪强,刘朵,等. 4种中药单体对人胰腺癌PANC-1细胞移植瘤生长的影响及分子机制探讨[J]. 中国中药杂志,2013,38(2):245-248.
[17]	陆文铨,邱彦,庞涛,等. 知母皂苷B-Ⅱ抑制人肺癌细胞A549细胞增殖和迁移的机制研究[J]. 中国药房,2016,27(10):1346-1349.
[18]	胡雅儿,王子玫,张永芳,等. 老年痴呆症药物治疗的一条新途径,知母皂甙元促进脑M受体生成改善记忆功能[J].世界科学技术(中医药现代化),2007,9(2):127-133.
[19]	陈勤,夏宗勤,胡雅儿. 知母皂苷元对痴呆模型大鼠脑内M受体密度分布的影响[J]. 激光生物学报,2003,12(6):445-449.
[20]	陈勤,夏宗勤,胡雅儿. 知母皂苷元对拟痴呆大鼠β-淀粉样肽沉积及胆碱能系统功能的影响[J]. 中国药理学通报,2002,18(4):390-393.
[21]	胡梅,胡雅儿,张蔚,等. 知母活性成分ZMS对老年大鼠脑M受体的调节作用[J]. 中华核医学杂志,2001,21(3):158-161.
[22]	张新战,戴晓莉. 知母皂苷用于老年痴呆大鼠效果观察[J]. 山东医药,2008,48(48):43-44.
[23]	Lee B,Jung K,Kim DH. Timosaponin AⅢ, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice[J]. Pharmacol Biochem Behav,2009,93(2):121-127.
[24]	刘卓,金英,刘婉珠,等. 知母皂苷对脂多糖引起的大鼠学习记忆障碍和炎症反应的影响[J]. 中国药理学通报,2010,26(10):1362-1366.
[25]	刘卓,隋海娟,闫恩志,等. 知母皂苷对脂多糖引起星形胶质细胞炎症因子释放的影响及机制[J]. 中国药理学通报,2012,28(7):970-974.
[26]	Li TJ,Qiu Y,Yang PY,et al. Timosaponin B-Ⅱ improves memory and learning dysfunction induced by cerebral ischemia in rats[J]. Neurosci Lett,2007, 421(2):147-151.
[27]	邓云,马百平,徐秋萍,等. 知母有效成分对拟痴呆模型大鼠学习记忆的影响及机制[J].中国药理学通报,2005,21(7):830-833.
[28]	成之福,王毅华,张桂英,等. 知母皂苷对谷氨酸致老年性痴呆模型小鼠的作用[J]. 中国医院药学杂志,2008,28(23):1997-1999.
[29]	隋海娟,马瑞国,刘佳颖,等. 知母皂苷对Aβ_1-42诱导的皮层神经元突触损伤的保护作用[J]. 中药药理与临床,2015,31(6):27-30.
[30]	马玉奎,李莉,刘国斌. 知母皂苷对三氯化铝致老年性痴呆模型大鼠的作用[J]. 齐鲁药事,2005,24(10):625-626.
[31]	王艳,王艳杰,宋少江,等. 知母总皂苷对β-淀粉样蛋白诱导PC12细胞凋亡的抑制作用[J]. 中国老年学杂志,2012,32(13):2778-2781.
[32]	王艳杰,柳春,王艳,等. 知母总皂苷对β淀粉样蛋白诱导的PC12细胞Bcl-2表达的影响[J]. 中国实验方剂学杂志,2013,19(12):208-211.
[33]	钟雷,谭洁,欧阳石,等. 知母皂苷B对大鼠海马注射β-AP(25~35)致tau蛋白磷酸化的影响[J]. 南方医科大学学报,2006,26(8):1106-1109.
[34]	王立军,金英,隋海娟,等. 知母皂苷元改善淀粉样β蛋白1-42引起的体外培养乳大鼠海马神经元的损伤[J]. 中国药理学与毒理学杂志,2013,27(4):1-6.
[35]	马玉奎,周晓棉,王立辉,等. 知母皂苷对D-半乳糖衰老模型小鼠的作用[J]. 沈阳药科大学学报,2004,21(6):450-453.
[36]	王琦,隋海娟,屈文慧,等. 知母皂苷元对谷氨酸引起的皮层神经元损伤的保护作用研究[J]. 中国药理学通报,2013,29(2):281-285.
[37]	杨成,金英,李世章,等. 知母总皂苷对老年大鼠学习记忆行为和海马突触相关蛋白表达的影响[J]. 中国药理学与毒理学杂志,2012,26(2):145-150.
[38]	徐江平. 知母皂苷对衰老大鼠脑M、N胆碱受体的调节作用[J]. 中国老年学杂志,2001,21(5):379-380.
[39]	隋海娟,马瑞国,刘卓,等. 知母皂苷对AD模型大鼠学习记忆能力及磷酸化Tau蛋白和胆碱乙酰基转移酶表达的影响[J]. 中药药理与临床,2016,32(2):71-73.
[40]	路明珠,张治强,伊佳,等. 知母皂苷B-Ⅱ抗抑郁作用及其机制研究[J]. 药学实践杂志,2010,28(4):283-287.
[41]	Ren LX,Luo YF,Li X,et al. Antidepressant-Like Effects of Sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae)[J]. Biol Pharm Bull,2006,29(11):2304-2306.
[42]	龚林,邱彦,刘静,等.知母总皂苷对血管性抑郁小鼠抑郁行为和脑组织病理学的影响[J]. 中国药物应用与监测,2017,14(2):88-92.
[43]	李素燕,赵振虎,裴海云,等. 知母皂苷AⅢ抗血栓作用研究[J]. 军事医学科学院院刊,2006,30(4):340-342.
[44]	Cong Y,Wang LM,Peng RJ,et al. Timosaponin AⅢ induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor[J]. Sci Rep,2016,6:1-13.
[45]	Kang LP,Zhang J,Cong Y,et al. Steroidal glycosides from the rhizomes of Anemarrhena asphodeloides and their anti-platelet aggregation activity[J]. Planta Med,2012,78(6):611-616.
[46]	Lu WQ,Qiu Y, Li TJ,et al. Antiplatelet and antithrombotic activities of timosaponin B-Ⅱ, an extract of Anemarrhena asphodeloides[J]. Clin Exp Pharmacol Physiol, 2011,38(7):430-434.
[47]	Kaname N,Zhang JY,Meng ZY,et al. Effect of timosaponin E1 and E2 on superoxide generation induced by various stimuli in human neutrophils and on platelet aggregation in human blood[J]. Clin Chim Acta, 2000,295(1-2):129-140.
[48]	韩兵,李春梅,李敏,等.知母皂苷的降脂及抗动脉粥样硬化作用[J]. 上海中医药杂志,2006,40(11):68-70.
[49]	付宝才,林娟,杨林海. 知母总皂苷对高脂血症大鼠肝脏低密度脂蛋白受体活性的影响[J]. 医学综述,2009,15(14):2226-2227.
[50]	Wang GJ,Lin LC,Chen CF,et al. Effect of timosaponin A-Ⅲ, from Anemarrhenae asphodeloides Bunge (Liliaceae), on calcium mobilization in vascular endothelial and smooth muscle cells and on vascular tension[J]. Life Sci,2002,71(9):1081-1090.
[51]	李泽松,李德良,黄坚,等.心血管相关基因芯片的制备及其在知母皂苷作用机制研究中的应用[J]. 药学学报,2003,38(7):496-500.
[52]	Yuan YL,Guo CR,Cui LL,et al. Timosaponin B-Ⅱ ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice[J].DrugDesign, Develop Ther, 2015:6247-6258.
[53]	Liu YW,Zhu X,Lu Q, et al. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats:involvement of amyloid-beta decrease in brain[J]. J Ethnopharmacol,2012, 139(1):194-200.
[54]	钟艳梅,钟静君,石忠峰,等.知母总皂苷干预T2DM大鼠的药效学研究[J]. 时珍国医国药,2017,28(1):71-74.
[55]	李春梅,高永林,李敏,等. 知母皂苷对小鼠血糖的影响[J]. 中药药理与临床,2005,21(4):22-23.
[56]	刘健,喻凯,王明奎,等.知母中OfficinalisininⅠ降糖机制及中枢神经保护研究[J]. 中华中医药杂志,2017,32(2):782-785.
[57]	杨茗,季晖,戴胜军,等. 菝葜皂苷元对去卵巢大鼠内分泌及抗氧化功能的影响[J]. 中草药,2007,38(2):245-247.
[58]	杨茗,季晖,戴胜军,等. 知母皂苷元对维A酸致小鼠骨质疏松的防治作用[J]. 中国天然药物,2006,4(3):219-223.
[59]	刘炳彤,李良昌,李光昭.知母皂苷对肥大细胞活化的影响[J]. 时珍国医国药,2016,27(5):1033-1035
[60]	李欣,陈长勋,郭娟.知母总皂苷对甲亢模型小鼠影响的实验研究[J]. 中华中医药学刊,2012,30(7):1581-1583.

Proportional views

通讯作者: 陈斌, [email protected]

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views(7617) PDF downloads(1050) Cited by()

Proportional views

Progress on pharmacological activities and mechanism of Anemarrhena saponin

Pudong New Area People's Hospital, Shanghai 201200, China;Shanghai Yangpu Hospital Affiliated to Tongji University, Shanghai 200090, China

Received Date: 2017-06-15

Rev Recd Date: 2017-09-20

Key words:

Abstract: As a traditional Chinese medicine, Anemarrhena saponin is one of the main components in Anemarrhena. Many pharmacological activities were reported in recent literatures, such as anti-tumor, anti-senile dementia, improving learning and memory, anti-clotting, anti-thrombus, reducing blood glucose and lipid, anti-depression, lowering blood pressure, and so on. In this paper, the pharmacological effects of the Anemarrhena saponin were summarized in four aspects which are anti-tumor, central nervous system, cardiovascular system and endocrine system to provide an important basis for further development of Anemarrhena.

HTML

Reference (60)

[1]	国家药典委员会. 中华人民共和国药典2015年版(一部)[S]. 北京:中国医药科技出版社,2015.
[2]	王迪,姜艳艳,石任兵. 中药知母质量控制方法研究[J]. 北京中医药大学学报,2011,34(4):263-265.
[3]	孙小明. 知母化学组分特征及其影响因素研究[D]. 北京:北京中医药大学,2008.
[4]	戴骏宇,喻凯,王明奎. 知母皂苷OfficinalisininⅠ对心肌缺血的保护作用及其机制研究[J]. 中药药理与临床,2017,3(3):27-30.
[5]	廖子君,张晓明,郭亚焕,等. 菝葜皂苷元对胃癌BGC-823细胞增殖、凋亡影响的实验研究[J]. 现代肿瘤医学,2010,18(6):1085-1087.
[6]	Ni Y,Gong XG,Lu M.,et al. Mitochondrial ROS burst as an early sign in sarsasapogenin-induced apoptosis in HepG2 cells[J]. Cell Biol Int,2008,32(3):337-343.
[7]	Bao WN,Pan HF,Lu M, et al. The apoptotic effect of sarsasapogenin from Anemarrhena asphodeloides on HepG2 human hepatoma cells[J]. Cell Biol Int,2007,31(9):887-892.
[8]	King FW,Fong S,Griffin C,et al. Timosaponin AⅢ is preferentially cytotoxic to tumor cells through inhibition of mTOR and induction of ER stress[J]. PLoS ONE,2009,4(9):e72-83.
[9]	Sy LK,Yan SC,Lok CN,et al. Timosaponin A-Ⅲ induces autophagy preceding mitochondria-mediated apoptosis in HeLa cancer cells[J]. Cancer Res,2008,68(24):10229-10237.
[10]	Kang YJ,Chung HJ,Nam JW,et al. Cytotoxic and antineoplastic activity of timosaponin A-Ⅲ for human colon cancer cells[J]. J Nat Prod,2011,74(4):701-706.
[11]	潘会君,莫小辉,冯彦军,等. 知母皂苷AⅢ对人脐静脉内皮细胞增殖和凋亡的影响[J].中国药房,2014,25(43):4049-4051.
[12]	潘会君,陈中建,章丹丹. 知母皂苷AⅢ对2种黑色素瘤细胞生长及巨噬细胞活化的影响[J]. 中国药师,2015,18(2):181-185.
[13]	潘会君,史海霞,陈中建,等. 知母皂苷AⅢ对黑色素瘤B16细胞生长和Bax,Bcl-2 mRNA的影响[J]. 中药新药与临床药理,2015,26(1):48-52.
[14]	Kim KM,Im A,Kim SH,et al. Timosaponin AⅢ inhibits melanoma cell migration by suppressing COX-2 and in vivo tumor metastasis[J].Cancer Science,2016,107(2):181-188.
[15]	谭希,潘会君,吴伟达,等. 知母皂苷AⅢ抑制人脑胶质瘤增殖生长的机制研究[J]. 中国中药杂志,2017,42(6):1160-1166.
[16]	潘会君,聂绪强,刘朵,等. 4种中药单体对人胰腺癌PANC-1细胞移植瘤生长的影响及分子机制探讨[J]. 中国中药杂志,2013,38(2):245-248.
[17]	陆文铨,邱彦,庞涛,等. 知母皂苷B-Ⅱ抑制人肺癌细胞A549细胞增殖和迁移的机制研究[J]. 中国药房,2016,27(10):1346-1349.
[18]	胡雅儿,王子玫,张永芳,等. 老年痴呆症药物治疗的一条新途径,知母皂甙元促进脑M受体生成改善记忆功能[J].世界科学技术(中医药现代化),2007,9(2):127-133.
[19]	陈勤,夏宗勤,胡雅儿. 知母皂苷元对痴呆模型大鼠脑内M受体密度分布的影响[J]. 激光生物学报,2003,12(6):445-449.
[20]	陈勤,夏宗勤,胡雅儿. 知母皂苷元对拟痴呆大鼠β-淀粉样肽沉积及胆碱能系统功能的影响[J]. 中国药理学通报,2002,18(4):390-393.
[21]	胡梅,胡雅儿,张蔚,等. 知母活性成分ZMS对老年大鼠脑M受体的调节作用[J]. 中华核医学杂志,2001,21(3):158-161.
[22]	张新战,戴晓莉. 知母皂苷用于老年痴呆大鼠效果观察[J]. 山东医药,2008,48(48):43-44.
[23]	Lee B,Jung K,Kim DH. Timosaponin AⅢ, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice[J]. Pharmacol Biochem Behav,2009,93(2):121-127.
[24]	刘卓,金英,刘婉珠,等. 知母皂苷对脂多糖引起的大鼠学习记忆障碍和炎症反应的影响[J]. 中国药理学通报,2010,26(10):1362-1366.
[25]	刘卓,隋海娟,闫恩志,等. 知母皂苷对脂多糖引起星形胶质细胞炎症因子释放的影响及机制[J]. 中国药理学通报,2012,28(7):970-974.
[26]	Li TJ,Qiu Y,Yang PY,et al. Timosaponin B-Ⅱ improves memory and learning dysfunction induced by cerebral ischemia in rats[J]. Neurosci Lett,2007, 421(2):147-151.
[27]	邓云,马百平,徐秋萍,等. 知母有效成分对拟痴呆模型大鼠学习记忆的影响及机制[J].中国药理学通报,2005,21(7):830-833.
[28]	成之福,王毅华,张桂英,等. 知母皂苷对谷氨酸致老年性痴呆模型小鼠的作用[J]. 中国医院药学杂志,2008,28(23):1997-1999.
[29]	隋海娟,马瑞国,刘佳颖,等. 知母皂苷对Aβ_1-42诱导的皮层神经元突触损伤的保护作用[J]. 中药药理与临床,2015,31(6):27-30.
[30]	马玉奎,李莉,刘国斌. 知母皂苷对三氯化铝致老年性痴呆模型大鼠的作用[J]. 齐鲁药事,2005,24(10):625-626.
[31]	王艳,王艳杰,宋少江,等. 知母总皂苷对β-淀粉样蛋白诱导PC12细胞凋亡的抑制作用[J]. 中国老年学杂志,2012,32(13):2778-2781.
[32]	王艳杰,柳春,王艳,等. 知母总皂苷对β淀粉样蛋白诱导的PC12细胞Bcl-2表达的影响[J]. 中国实验方剂学杂志,2013,19(12):208-211.
[33]	钟雷,谭洁,欧阳石,等. 知母皂苷B对大鼠海马注射β-AP(25~35)致tau蛋白磷酸化的影响[J]. 南方医科大学学报,2006,26(8):1106-1109.
[34]	王立军,金英,隋海娟,等. 知母皂苷元改善淀粉样β蛋白1-42引起的体外培养乳大鼠海马神经元的损伤[J]. 中国药理学与毒理学杂志,2013,27(4):1-6.
[35]	马玉奎,周晓棉,王立辉,等. 知母皂苷对D-半乳糖衰老模型小鼠的作用[J]. 沈阳药科大学学报,2004,21(6):450-453.
[36]	王琦,隋海娟,屈文慧,等. 知母皂苷元对谷氨酸引起的皮层神经元损伤的保护作用研究[J]. 中国药理学通报,2013,29(2):281-285.
[37]	杨成,金英,李世章,等. 知母总皂苷对老年大鼠学习记忆行为和海马突触相关蛋白表达的影响[J]. 中国药理学与毒理学杂志,2012,26(2):145-150.
[38]	徐江平. 知母皂苷对衰老大鼠脑M、N胆碱受体的调节作用[J]. 中国老年学杂志,2001,21(5):379-380.
[39]	隋海娟,马瑞国,刘卓,等. 知母皂苷对AD模型大鼠学习记忆能力及磷酸化Tau蛋白和胆碱乙酰基转移酶表达的影响[J]. 中药药理与临床,2016,32(2):71-73.
[40]	路明珠,张治强,伊佳,等. 知母皂苷B-Ⅱ抗抑郁作用及其机制研究[J]. 药学实践杂志,2010,28(4):283-287.
[41]	Ren LX,Luo YF,Li X,et al. Antidepressant-Like Effects of Sarsasapogenin from Anemarrhena asphodeloides BUNGE (Liliaceae)[J]. Biol Pharm Bull,2006,29(11):2304-2306.
[42]	龚林,邱彦,刘静,等.知母总皂苷对血管性抑郁小鼠抑郁行为和脑组织病理学的影响[J]. 中国药物应用与监测,2017,14(2):88-92.
[43]	李素燕,赵振虎,裴海云,等. 知母皂苷AⅢ抗血栓作用研究[J]. 军事医学科学院院刊,2006,30(4):340-342.
[44]	Cong Y,Wang LM,Peng RJ,et al. Timosaponin AⅢ induces antiplatelet and antithrombotic activity via Gq-mediated signaling by the thromboxane A2 receptor[J]. Sci Rep,2016,6:1-13.
[45]	Kang LP,Zhang J,Cong Y,et al. Steroidal glycosides from the rhizomes of Anemarrhena asphodeloides and their anti-platelet aggregation activity[J]. Planta Med,2012,78(6):611-616.
[46]	Lu WQ,Qiu Y, Li TJ,et al. Antiplatelet and antithrombotic activities of timosaponin B-Ⅱ, an extract of Anemarrhena asphodeloides[J]. Clin Exp Pharmacol Physiol, 2011,38(7):430-434.
[47]	Kaname N,Zhang JY,Meng ZY,et al. Effect of timosaponin E1 and E2 on superoxide generation induced by various stimuli in human neutrophils and on platelet aggregation in human blood[J]. Clin Chim Acta, 2000,295(1-2):129-140.
[48]	韩兵,李春梅,李敏,等.知母皂苷的降脂及抗动脉粥样硬化作用[J]. 上海中医药杂志,2006,40(11):68-70.
[49]	付宝才,林娟,杨林海. 知母总皂苷对高脂血症大鼠肝脏低密度脂蛋白受体活性的影响[J]. 医学综述,2009,15(14):2226-2227.
[50]	Wang GJ,Lin LC,Chen CF,et al. Effect of timosaponin A-Ⅲ, from Anemarrhenae asphodeloides Bunge (Liliaceae), on calcium mobilization in vascular endothelial and smooth muscle cells and on vascular tension[J]. Life Sci,2002,71(9):1081-1090.
[51]	李泽松,李德良,黄坚,等.心血管相关基因芯片的制备及其在知母皂苷作用机制研究中的应用[J]. 药学学报,2003,38(7):496-500.
[52]	Yuan YL,Guo CR,Cui LL,et al. Timosaponin B-Ⅱ ameliorates diabetic nephropathy via TXNIP, mTOR, and NF-κB signaling pathways in alloxan-induced mice[J].DrugDesign, Develop Ther, 2015:6247-6258.
[53]	Liu YW,Zhu X,Lu Q, et al. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats:involvement of amyloid-beta decrease in brain[J]. J Ethnopharmacol,2012, 139(1):194-200.
[54]	钟艳梅,钟静君,石忠峰,等.知母总皂苷干预T2DM大鼠的药效学研究[J]. 时珍国医国药,2017,28(1):71-74.
[55]	李春梅,高永林,李敏,等. 知母皂苷对小鼠血糖的影响[J]. 中药药理与临床,2005,21(4):22-23.
[56]	刘健,喻凯,王明奎,等.知母中OfficinalisininⅠ降糖机制及中枢神经保护研究[J]. 中华中医药杂志,2017,32(2):782-785.
[57]	杨茗,季晖,戴胜军,等. 菝葜皂苷元对去卵巢大鼠内分泌及抗氧化功能的影响[J]. 中草药,2007,38(2):245-247.
[58]	杨茗,季晖,戴胜军,等. 知母皂苷元对维A酸致小鼠骨质疏松的防治作用[J]. 中国天然药物,2006,4(3):219-223.
[59]	刘炳彤,李良昌,李光昭.知母皂苷对肥大细胞活化的影响[J]. 时珍国医国药,2016,27(5):1033-1035
[60]	李欣,陈长勋,郭娟.知母总皂苷对甲亢模型小鼠影响的实验研究[J]. 中华中医药学刊,2012,30(7):1581-1583.

Message Board

Progress on pharmacological activities and mechanism of Anemarrhena saponin

doi: 10.3969/j.issn.1006-0111.2018.01.005

Abstract

References

Proportional views

通讯作者: 陈斌, [email protected]

Article Metrics

Related

Proportional views